Advertisement

Advertisement

Departments

Advertisement

Advertisement



Dec
08
Today In Oncology
Phase Ib/II Study of BCMA-Directed CAR T-Cell Therapy for Pretreated Multiple Myeloma
Next Big Advance After CAR T-Cell Therapy May Be the Bispecific Antibody Mosunetuzumab
Geriatric Assessment–Guided Multidisciplinary Care May Benefit Older Patients Undergoing HCT
Assessing Cancer Pain Management in the Era of the Opioid Epidemic
DUOX2 Mutation in Familial Thyroid Cancers
View More 
Advertisement
Most Read Stories
I’m Not Dying of Cancer: I’m Living With Cancer
Secondary Surgical Cytoreduction Plus Chemotherapy vs Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Management of HER2-Positive Breast Cancer: Business as Usual?
Emerging Alternatives in the Third-Line Setting for Metastatic HER2-Positive Breast Cancer
FDA Approves Atezolizumab in Combination With Chemotherapy for First-Line Treatment of Metastatic Nonsquamous NSCLC
View More 
Most Viewed Videos
Robin L. Jones, MD, MBBS, on Advanced Angiosarcoma: TAPPAS Trial of a Novel Monoclonal Antibody Plus Pazopanib
Solange Peters, MD, PhD, on NSCLC: CheckMate 227 Trial of Nivolumab/Ipilimumab vs Chemotherapy
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
Nadine Housri, MD, on Online Tumor Boards: A New Resource for Practicing Oncologists
Jorge J. Castillo, MD, on Evolution of Therapy for Relapsed/Refractory Multiple Myeloma
View More 
© 2019 HSP News Service, L.L.C.